Home » Pharmacology » 7-TM Receptors » 5-HT Receptors » 5-HT₁ Receptors » 5-HT_1A Receptors » BP 554 maleate

BP 554 maleate

Cat. No. 0556

Price and Availability

For BP 554 maleate pricing & availability please select your country from the drop down menu:
Submit

By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 1-[3-(3,4-Methylenedioxyphenoxy)propyl]-4-phenyl-piperazine maleate

Biological Activity

Selective 5-HT_1A agonist.

Technical Data

M.Wt:

456.48

Formula:

C₂₀H₂₄N₂O₃.C₄H₄O₄

Solubility:

Soluble to 100 mM in DMSO

Purity:

>99 %

Storage:

Store at RT

CAS No:

82900-57-0

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Resources

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch

Safety Data Sheet: View Safety Data Sheet

References

Matsuda et al (1989) Agonist activity of a novel compound, 1-[3-(3,4-methylenedioxyphenoxy)propyl]-4-phenyl piperazine (BP-554) at central 5-HT_1A receptors. Eur.J.Pharmacol. 170 75. PMID: 2533078.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

5-HT₁ Receptors

5-HT_1A Receptors

Keywords: BP 554 maleate, supplier, Selective, 5-HT1A, agonists, Serotonin, Receptors, 5-HT1, BP554, maleate

Quick Order

Find multiple products by catalog number

5-HT Review

Written by Nicholas Barnes and John Neumaier, leading experts. Request a copy or view PDF today.

Neurobiology of Parkinson's Disease

Written by A. Schapira

'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and summarizes current and novel therapeutic interventions.

7-TM Receptor Signaling

Written by T. Kenakin et al

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

Antidepressants - Current and Future Targets

Written by P. Skolnich et al

'Antidepressants - Current and Future Targets' provides an overview of the current and future targets for the treatment of major depressive disorder.

New Product Guide

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

Twitter Updates

Follow @Tocris on Twitter

Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.